Cargando…
Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders
Autores principales: | Nakamura, Masakatsu, Otsuka, Toshimi, Kumagai, Motona, Arisawa, Tomiyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851178/ https://www.ncbi.nlm.nih.gov/pubmed/34248122 http://dx.doi.org/10.2169/internalmedicine.7725-21 |
Ejemplares similares
-
Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer
por: Nakamura, Masakatsu, et al.
Publicado: (2020) -
Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019) -
Systemic Psoriasiform Dermatitis Appeared after the Administration of Pembrolizumab
por: Suzuki, Manabu, et al.
Publicado: (2019) -
Focal Eosinophilic Myositis
por: Kawabe, Akio, et al.
Publicado: (2019) -
Venous Aneurysm of the Jejunum
por: Kumagai, Kenta, et al.
Publicado: (2019)